Buprenorph8mg+Nalox 2mg SL tab/PAC-30

General description:
Buprenorphine 8mg + Naloxone 2mg sublingual (SL) tablets, HDPE bottle containing 30 sublingual tablets.

Sublingual (SL) tablets are NOT to be swallowed but placed under the tongue (sublingual) and allowed to dissolve slowly.

Technical specifications:
Each sublingual tablet contains 8mg Buprenorphine (as hydrochloride) and 2mg Naloxone (as hydrochloride dihydrate).

Therapeutic class:
Agents for Opioid Dependence & Opioid Withdrawal.
Buprenorphine is an opioid partial agonist. Naloxone is an opioid antagonist.

Indication:
Substitution treatment for opioid drug dependence, within a framework of medical, social, and psychological treatment.

Dosage, instruction for use:
As directed by Physician.

Sublingual (SL) tablets are NOT to be swallowed but placed under the tongue (sublingual) and allowed to dissolve slowly. Please refer to the guideline WHO Model Formulary 2008:
https ://www.who.int/selection_medicines/list/WMF2008.pdf

Shelf life:
24 months

Storage conditions:
Do not store above 25 Celsius degrees.
This product must be transported between +15°C to +25°C unless otherwise specified.

Component of a kit:
Not a part of a kit.

Alternative products:
The product may also be available in other strengths.